AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35148643 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaOCl)
Number of subjects: 16
Study 35148643 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (NSS)
Number of subjects: 16
Study 32889038 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with Lavender essential oil
Number of subjects: 105
Study 32889038 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with Citrus Aurantium essential oil
Number of subjects: 105
Study 32889038 — intervention group
Group type: COMPARATOR
Intervention: Control group (foot massage)
Number of subjects: 105
Study 33877646 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week classroom education and mindfulness-based physical activity intervention
Number of subjects: 110
Study 33877646 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 110
Study 33478383 — intervention group
Group type: EXPERIMENTAL
Intervention: PgNACs under salinity stress
Number of subjects: 151
Study 33478383 — intervention group
Group type: EXPERIMENTAL
Intervention: PgNACs under drought stress
Number of subjects: 151
Study 33478383 — intervention group
Group type: EXPERIMENTAL
Intervention: PgNACs examined by quantitative reverse transcription‐PCR
Number of subjects: 151
Study 32843075 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent enteral feeding with a high-protein formula
Number of subjects: 60
Study 32843075 — intervention group
Group type: COMPARATOR
Intervention: Continuous enteral feeding with a high-protein formula
Number of subjects: 60
Study 32843075 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent enteral feeding
Number of subjects: 60
Study 34161946 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based mHealth program (3-month program with nurse case management and video messages)
Number of subjects: 68
Study 34161946 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based mHealth program
Number of subjects: 68
Study 34161946 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 68
Study 35740202 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (400–600 µg/kg/d)
Number of subjects: 983
Study 35740202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 983
Study 32531070 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (desflurane/remifentanil)
Number of subjects: 67
Study 32531070 — intervention group
Group type: COMPARATOR
Intervention: TIVA (propofol/remifentanil)
Number of subjects: 67
Study 32531070 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (sevoflurane/remifentanil)
Number of subjects: 67
Study 35195045 — intervention group
Group type: EXPERIMENTAL
Intervention: Handgrip exercise (30 minutes)
Number of subjects: 11
Study 35195045 — intervention group
Group type: COMPARATOR
Intervention: Control group (time-control)
Number of subjects: 11
Study 33598997 — intervention group
Group type: EXPERIMENTAL
Intervention: Training session for compression bandaging
Number of subjects: 55
Study 36267612 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of hyperbaric bupivacaine (0.5%)
Number of subjects: 40
Study 36267612 — intervention group
Group type: COMPARATOR
Intervention: 12 mg of hyperbaric bupivacaine (0.5%)
Number of subjects: 40
Study 35358097 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy
Number of subjects: 298
Study 35358097 — intervention group
Group type: COMPARATOR
Intervention: Standard gauze dressing
Number of subjects: 298
Study 33151698 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine ingestion
Number of subjects: 0
Study 33151698 — intervention group
Group type: COMPARATOR
Intervention: Nicotine abstinence
Number of subjects: 0
Study 32543162 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate nostril breathing (ANB) exercise for 4 weeks
Number of subjects: 100
Study 32543162 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study 33597131 — intervention group
Group type: EXPERIMENTAL
Intervention: ACC/AHA 2017 guideline recommendation for antihypertensive medication
Number of subjects: 3092
Study 33597131 — intervention group
Group type: COMPARATOR
Intervention: JNC7 guideline recommendation for antihypertensive medication
Number of subjects: 3092
Study 33597131 — intervention group
Group type: COMPARATOR
Intervention: ESH/ESC 2013 guideline recommendation for antihypertensive medication
Number of subjects: 3092
Study 33597131 — intervention group
Group type: COMPARATOR
Intervention: ESC/ESH 2018 guideline recommendation for antihypertensive medication
Number of subjects: 3092
Study 33597131 — intervention group
Group type: COMPARATOR
Intervention: WHO/ISH 2003 guideline recommendation for antihypertensive medication
Number of subjects: 3092
Study 33597131 — intervention group
Group type: COMPARATOR
Intervention: ISH 2020 guideline recommendation for antihypertensive medication
Number of subjects: 3092
Study 32246196 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 373
Study 32246196 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of psychoeducation and cognitive behavioral therapy (CBT)
Number of subjects: 373
Study 32246196 — intervention group
Group type: COMPARATOR
Intervention: Combination of psychoeducation and CBT
Number of subjects: 373
Study 33719692 — intervention group
Group type: EXPERIMENTAL
Intervention: Wording condition: refusal
Number of subjects: 175
Study 33719692 — intervention group
Group type: COMPARATOR
Intervention: Wording condition: not willing/non-consent
Number of subjects: 175
Study 33719692 — intervention group
Group type: EXPERIMENTAL
Intervention: Men's interpretations
Number of subjects: 175
Study 33719692 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's interpretations
Number of subjects: 175
Study 32341113 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 283
Study 32341113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283
Study 37640651 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic off-clamp tumor evacuation (Group 2)
Number of subjects: 42
Study 37640651 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic standard nephron-sparing surgery (Group 1)
Number of subjects: 42
Study 32890442 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable polymer sirolimus eluting stent (BP‐SES)
Number of subjects: 3717
Study 32890442 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer everolimus eluting stent (DP‐EES)
Number of subjects: 3717
Study 33720588 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydexa with phenylephrinum (topical nasal spray)
Number of subjects: 100
Study 33720588 — intervention group
Group type: COMPARATOR
Intervention: Systemic antibacterial therapy and long‐acting local decongestants
Number of subjects: 100
Study 35760691 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with propofol and opioids (Group A)
Number of subjects: 103
Study 35760691 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with propofol and opioids plus interfascial blocks (Group B)
Number of subjects: 103
Study 34527615 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin + Methocarbamol (Group I + M)
Number of subjects: 64
Study 34527615 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (Group I)
Number of subjects: 64
Study 32734844 — intervention group
Group type: EXPERIMENTAL
Intervention: HS‐UnSS (holding a hockey stick in a flexed posture)
Number of subjects: 12
Study 32734844 — intervention group
Group type: COMPARATOR
Intervention: UnSS (traditional unanticipated sidestepping)
Number of subjects: 12
Study 32734844 — intervention group
Group type: EXPERIMENTAL
Intervention: HS‐UnSS
Number of subjects: 12
Study 33823786 — intervention group
Group type: EXPERIMENTAL
Intervention: Group TAP (20 mL of 0.5% ropivacaine per side)
Number of subjects: 82
Study 33823786 — intervention group
Group type: COMPARATOR
Intervention: Group Control (normal saline)
Number of subjects: 82
Study 33823786 — intervention group
Group type: EXPERIMENTAL
Intervention: Group TAP
Number of subjects: 82
Study 33823786 — intervention group
Group type: COMPARATOR
Intervention: Group Control
Number of subjects: 82
Study 34862870 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone combined with atorvastatin
Number of subjects: 90
Study 34862870 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 90
Study 33181534 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 35
Study 33181534 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 35
Study 35996776 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless glue free conjunctival autograft
Number of subjects: 100
Study 35996776 — intervention group
Group type: COMPARATOR
Intervention: Sutured (vicryl 8‐0) conjunctival autograft
Number of subjects: 100
Study 32242289 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-h LINKS
Number of subjects: 84
Study 32242289 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-h LINKS
Number of subjects: 84
Study 32242289 — intervention group
Group type: COMPARATOR
Intervention: 1-h Active Control
Number of subjects: 84
Study 32242289 — intervention group
Group type: COMPARATOR
Intervention: 2-h Active Control
Number of subjects: 84
Study 35411186 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Serratus Anterior Plane Block (SAPB) with 40 mL 0.375% ropivacaine
Number of subjects: 40
Study 35411186 — intervention group
Group type: COMPARATOR
Intervention: Placebo control with normal saline
Number of subjects: 40
Study 34561541 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea combined with α-glucosyl hesperidin (GT-gH)
Number of subjects: 60
Study 34561541 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35413933 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV self-testing via online distribution (oral fluid- or blood-based HCV self-test kit mailed)
Number of subjects: 750
Study 35413933 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV self-testing via online distribution
Number of subjects: 750
Study 35413933 — intervention group
Group type: COMPARATOR
Intervention: Standard care (clinic-based HCV antibody testing)
Number of subjects: 750
Study 32975624 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with SSNB and ANB (Group 1)
Number of subjects: 40
Study 32975624 — intervention group
Group type: COMPARATOR
Intervention: SSNB and ANB alone (Group 2)
Number of subjects: 40
Study 32740723 — intervention group
Group type: EXPERIMENTAL
Intervention: Announced exercise with 33% reduction in meal bolus (A-RB)
Number of subjects: 37
Study 32740723 — intervention group
Group type: EXPERIMENTAL
Intervention: Announced exercise with full meal bolus (A-FB)
Number of subjects: 37
Study 32740723 — intervention group
Group type: COMPARATOR
Intervention: Unannounced exercise with full meal bolus (U-FB)
Number of subjects: 37
Study 32740723 — intervention group
Group type: COMPARATOR
Intervention: Comparison of A-RB vs U-FB
Number of subjects: 37
Study 36005503 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/day SXRG84 for six weeks
Number of subjects: 64
Study 36005503 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g/day SXRG84 for six weeks
Number of subjects: 64
Study 36005503 — intervention group
Group type: COMPARATOR
Intervention: Placebo for six weeks followed by 2 g/day SXRG84 for six weeks (Study 2)
Number of subjects: 64
Study 34520311 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5-h time interval
Number of subjects: 70
Study 34520311 — intervention group
Group type: COMPARATOR
Intervention: 4-h time interval
Number of subjects: 70
Study 35199421 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 527
Study 35199421 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 527
Study 34654349 — intervention group
Group type: EXPERIMENTAL
Intervention: ZSP1273 (single or multiple doses)
Number of subjects: 100
Study 34654349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35245416 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic Partial Meniscectomy (APM)
Number of subjects: 302
Study 35245416 — intervention group
Group type: COMPARATOR
Intervention: Physical Therapy
Number of subjects: 302
Study 32919076 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 199
Study 32919076 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 199
Study 32240370 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Child Interaction Therapy Emotion Development (PCIT-ED)
Number of subjects: 0
Study 34628482 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg JNJ-48816274
Number of subjects: 18
Study 34628482 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg JNJ-48816274
Number of subjects: 18
Study 34628482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 34673259 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 65
Study 34673259 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 65
Study 32658921 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy treatment for hrHPV positive women
Number of subjects: 16
Study 32658921 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider perceptions of barriers to treatment
Number of subjects: 16
Study 32658921 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators of treatment
Number of subjects: 16
Study 35380718 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron supplementation
Number of subjects: 186
Study 35380718 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional tests
Number of subjects: 186
Study 34336894 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole 10 mg
Number of subjects: 150
Study 34336894 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaprazole 20 mg
Number of subjects: 150
Study 34336894 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaprazole 40 mg
Number of subjects: 150
Study 36361056 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-construction of materials (SELF)
Number of subjects: 111
Study 36361056 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 111
Study 32987282 — intervention group
Group type: EXPERIMENTAL
Intervention: High emotional arousal (measured by fundamental frequency, f0) during rationale development
Number of subjects: 197
Study 32987282 — intervention group
Group type: EXPERIMENTAL
Intervention: Insight into the rationale (assessed by raters)
Number of subjects: 197
Study 32987282 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom severity (self- and rater assessed at beginning and end of therapy)
Number of subjects: 197
Study 34255325 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional configuration
Number of subjects: 28
Study 34255325 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional to failure
Number of subjects: 28
Study 34255325 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest-pause
Number of subjects: 28
Study 34255325 — intervention group
Group type: COMPARATOR
Intervention: Inter-repetition rest
Number of subjects: 28
Study 33991479 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual multimodal screening (MMS)
Number of subjects: 202562
Study 33991479 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual transvaginal ultrasound screening (USS)
Number of subjects: 202562
Study 33991479 — intervention group
Group type: COMPARATOR
Intervention: No screening
Number of subjects: 202562
Study 33016149 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiangshao granules
Number of subjects: 300
Study 33016149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 32803641 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvenous phrenic nerve stimulation with the remedē System
Number of subjects: 0
Study 32803641 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35669366 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological support intervention based on structure‐process‐result three‐dimensional quality assessment
Number of subjects: 110
Study 35669366 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing measures (Control)
Number of subjects: 110
Study 33894334 — intervention group
Group type: EXPERIMENTAL
Intervention: Active left dorsolateral prefrontal cortex (DLPFC) tDCS
Number of subjects: 19
Study 33894334 — intervention group
Group type: COMPARATOR
Intervention: Sham DLPFC-tDCS
Number of subjects: 19
Study 33050897 — intervention group
Group type: EXPERIMENTAL
Intervention: BREN+AVD (brentuximab vedotin + AVD)
Number of subjects: 0
Study 33050897 — intervention group
Group type: COMPARATOR
Intervention: ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Number of subjects: 0
Study 33784487 — intervention group
Group type: EXPERIMENTAL
Intervention: FitSkills exercise program (12 weeks, twice-weekly sessions)
Number of subjects: 163
Study 33784487 — intervention group
Group type: EXPERIMENTAL
Intervention: FitSkills exercise program
Number of subjects: 163
Study 33666166 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable monitor (PM) sleep testing at home
Number of subjects: 20
Study 33666166 — intervention group
Group type: COMPARATOR
Intervention: Portable monitor (PM) sleep testing in-laboratory
Number of subjects: 20
Study 33666166 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient satisfaction with PM
Number of subjects: 20
Study 33999545 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided complete revascularization
Number of subjects: 1163
Study 33999545 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided complete revascularization
Number of subjects: 1163
Study 36115888 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg subcutaneously every 6 months
Number of subjects: 279
Study 36115888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study 32675674 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete repair with posterior interval slide
Number of subjects: 58
Study 32675674 — intervention group
Group type: COMPARATOR
Intervention: Partial repair without posterior interval slide
Number of subjects: 58
Study 34086998 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 147
Study 34086998 — intervention group
Group type: COMPARATOR
Intervention: Palpation and landmarks (Control)
Number of subjects: 147
Study 32356115 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept 125 mg weekly for 24 weeks
Number of subjects: 424
Study 32356115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 424
Study 32356115 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 424
Study 35035429 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid based nutritional supplement for pregnant and lactating women LNS-PLW
Number of subjects: 60
Study 32810850 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic alone
Number of subjects: 55
Study 32810850 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic plus antispasmodic
Number of subjects: 55
Study 32810850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 35614509 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent LIVE intervention (including medication review by the PwD’s regular GPs)
Number of subjects: 280
Study 35614509 — intervention group
Group type: COMPARATOR
Intervention: Health care as usual (control condition)
Number of subjects: 280
Study 36398582 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal early mobility training regimens
Number of subjects: 2700
Study 36398582 — intervention group
Group type: COMPARATOR
Intervention: Reference arm (usual mobility training)
Number of subjects: 2700
Study 34889235 — intervention group
Group type: EXPERIMENTAL
Intervention: modified GGQL formula plus basic antitumor therapy
Number of subjects: 120
Study 34889235 — intervention group
Group type: COMPARATOR
Intervention: basic antitumor therapy
Number of subjects: 120
Study 34197772 — intervention group
Group type: EXPERIMENTAL
Intervention: Emtricitabine and tenofovir alafenamide (200/25 mg)
Number of subjects: 5387
Study 34197772 — intervention group
Group type: COMPARATOR
Intervention: Emtricitabine and tenofovir disoproxil fumarate (200/300 mg)
Number of subjects: 5387
Study 34197772 — intervention group
Group type: EXPERIMENTAL
Intervention: Emtricitabine and tenofovir alafenamide
Number of subjects: 5387
Study 34941609 — intervention group
Group type: COMPARATOR
Intervention: Traditional squats (TRAD)
Number of subjects: 37
Study 34941609 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional plus modified squats (EXP)
Number of subjects: 37
Study 34941609 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TRAD and EXP)
Number of subjects: 37
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine U-100
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall rates of moderately increased albuminuria
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall rates of severely increased albuminuria
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall rates of renal impairment
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall rates of diabetic peripheral neuropathy
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: MACE (major adverse cardiovascular events)
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization for heart failure
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: Death from cardiovascular causes
Number of subjects: 5047
Study 36129997 — intervention group
Group type: EXPERIMENTAL
Intervention: All deaths
Number of subjects: 5047
Study 33378703 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional substrate ablation
Number of subjects: 40